These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10101580

  • 1. The immunopathogenesis of multiple sclerosis.
    Giovannoni G.
    Baillieres Clin Neurol; 1997 Oct; 6(3):387-407. PubMed ID: 10101580
    [Abstract] [Full Text] [Related]

  • 2. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H.
    Verh Dtsch Ges Pathol; 1996 Oct; 80():109-15. PubMed ID: 9064993
    [Abstract] [Full Text] [Related]

  • 3. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y, Suárez-Luis I.
    Rev Neurol; 1996 Oct; 36(7):649-52. PubMed ID: 12666047
    [Abstract] [Full Text] [Related]

  • 4. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy.
    Kieseier BC, Archelos JJ, Storch M, Gold R, Hartung HP.
    Wien Klin Wochenschr; 1999 Sep 17; 111(17):728-37. PubMed ID: 10526397
    [Abstract] [Full Text] [Related]

  • 5. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ, Suidan GL, McDole J, Pirko I.
    Int Rev Neurobiol; 2007 Sep 17; 79():73-97. PubMed ID: 17531838
    [Abstract] [Full Text] [Related]

  • 6. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P, Raus J.
    Acta Neurol Belg; 1999 Mar 17; 99(1):65-9. PubMed ID: 10218096
    [Abstract] [Full Text] [Related]

  • 7. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V, Taradi SK, Andreis I, Zupancić V, Taradi M.
    Lijec Vjesn; 2001 Mar 17; 123(3-4):81-8. PubMed ID: 11488222
    [Abstract] [Full Text] [Related]

  • 8. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA, Millward JM, Owens T.
    J Neuroimmunol; 2007 Nov 17; 191(1-2):79-85. PubMed ID: 17920696
    [Abstract] [Full Text] [Related]

  • 9. Immunologic aspects of multiple sclerosis.
    Boppana S, Huang H, Ito K, Dhib-Jalbut S.
    Mt Sinai J Med; 2011 Nov 17; 78(2):207-20. PubMed ID: 21425265
    [Abstract] [Full Text] [Related]

  • 10. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF, Martin R.
    Nat Immunol; 2007 Sep 17; 8(9):913-9. PubMed ID: 17712344
    [Abstract] [Full Text] [Related]

  • 11. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL, Wiendl H.
    Hum Immunol; 2008 Nov 17; 69(11):797-804. PubMed ID: 18723060
    [Abstract] [Full Text] [Related]

  • 12. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.
    Ann Neurol; 2009 Sep 17; 66(3):310-22. PubMed ID: 19798635
    [Abstract] [Full Text] [Related]

  • 13. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
    Friese MA, Fugger L.
    Brain; 2005 Aug 17; 128(Pt 8):1747-63. PubMed ID: 15975943
    [Abstract] [Full Text] [Related]

  • 14. Lessons from multiple sclerosis: models, concepts, observations.
    Wekerle H.
    Ann Rheum Dis; 2008 Dec 17; 67 Suppl 3():iii56-60. PubMed ID: 19022815
    [Abstract] [Full Text] [Related]

  • 15. Autoimmune aspects of demyelinating diseases.
    Swanborg RH.
    Immunol Ser; 1990 Dec 17; 52():155-67. PubMed ID: 2091778
    [No Abstract] [Full Text] [Related]

  • 16. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
    Hellings N, Raus J, Stinissen P.
    Autoimmun Rev; 2004 Jun 17; 3(4):267-75. PubMed ID: 15246022
    [Abstract] [Full Text] [Related]

  • 17. Immunologic aspects of multiple sclerosis.
    Taylor RS.
    Phys Med Rehabil Clin N Am; 1998 Aug 17; 9(3):525-36, v. PubMed ID: 9894106
    [Abstract] [Full Text] [Related]

  • 18. The initiation of the autoimmune response in multiple sclerosis.
    Markovic-Plese S, Pinilla C, Martin R.
    Clin Neurol Neurosurg; 2004 Jun 17; 106(3):218-22. PubMed ID: 15177771
    [Abstract] [Full Text] [Related]

  • 19. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.
    Centonze D, Muzio L, Rossi S, Furlan R, Bernardi G, Martino G.
    Cell Death Differ; 2010 Jul 17; 17(7):1083-91. PubMed ID: 19927157
    [Abstract] [Full Text] [Related]

  • 20. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M, Dubucquoi S, Lefranc D, Zéphir H, De Seze J, Vermersch P, Prin L.
    Immunol Lett; 2005 Jan 15; 96(1):11-26. PubMed ID: 15585303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.